Skip to main content
NERV
NASDAQ Life Sciences

10% Holder Federated Hermes Files Intent to Sell $2.12M in NERV Shares

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$7.86
Mkt Cap
$343.599M
52W Low
$1.15
52W High
$12.46
Market data snapshot near publication time

summarizeSummary

A 10% institutional stockholder, Federated Hermes Kaufmann Small Cap Fund, filed a Form 144 to sell 264,615 shares of Minerva Neurosciences common stock, valued at approximately $2.12 million.


check_boxKey Events

  • Intent to Sell Shares

    Federated Hermes Kaufmann Small Cap Fund, a 10% stockholder, filed a Form 144 indicating intent to sell 264,615 shares of Minerva Neurosciences common stock.

  • Significant Value

    The proposed sale has an approximate market value of $2,116,920.00.

  • Institutional Filer

    The filer is an institutional investor, not an executive or director of the company.


auto_awesomeAnalysis

This Form 144 indicates an intent by Federated Hermes Kaufmann Small Cap Fund, a 10% institutional stockholder, to sell a notable block of shares. While the proposed sale represents approximately 0.62% of the company's market capitalization, it is a substantial dollar amount for a single transaction. For institutional investors, such filings often reflect portfolio rebalancing or liquidity needs rather than a fundamental change in their view of the company's prospects. However, any large intent to sell can create an overhang on the stock, and investors should monitor if the actual sale occurs and if other institutional holders follow suit.

At the time of this filing, NERV was trading at $7.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $343.6M. The 52-week trading range was $1.15 to $12.46. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NERV - Latest Insights

NERV
Apr 23, 2026, 7:02 AM EDT
Filing Type: DEFA14A
Importance Score:
7
NERV
Apr 23, 2026, 7:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
NERV
Apr 10, 2026, 9:20 AM EDT
Filing Type: PRE 14A
Importance Score:
7
NERV
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
NERV
Mar 11, 2026, 9:20 AM EDT
Filing Type: S-3
Importance Score:
8
NERV
Mar 11, 2026, 8:00 AM EDT
Filing Type: 10-K
Importance Score:
9
NERV
Mar 11, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
8
NERV
Mar 11, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
NERV
Mar 10, 2026, 5:15 PM EDT
Filing Type: 144
Importance Score:
7
NERV
Mar 10, 2026, 5:15 PM EDT
Filing Type: 144
Importance Score:
7